Developmental Delay Disorders
5
0
0
5
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Treatment Research
6 treatments under study, led by Family Navigation
Research Leaders
9 sponsors active, led by National Human Genome Research Institute (NHGRI)
Related Conditions
Often studied with 13 related conditions
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 5 trials
100.0%
+13.4% vs benchmark
0%
0 trials in Phase 3/4
0%
0 of 5 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 5 completed trials
Clinical Trials (5)
Project EARLY: Engagement, Assessment, Referral, & Linkage for Young Children
Clinical and Genetic Studies on Holoprosencephaly
Treatment Strategies for Children With Smith-Magenis Syndrome
Prolonged Outcomes After Nitric Oxide (PrONOx)
Feasibility Study for PANDAS
Research Network
Common Treatments
- Family Navigation1
- Phototherapy Bright Light1
- Dtr Melatonin Nih Cc Pds1
- Long Term Followup1
- Melatonin Cr1
Active Sponsors
- National Human Genome Research Institute (NHGRI)2
- Children's Hospital of Philadelphia2
- University of Pittsburgh1
- National Heart, Lung, and Blood Institute (NHLBI)1
- Yale University1
Top Investigators
Children's Hospital of Philadelphia
Boston University
National Human Genome Research Institute (NHGRI)
University of Pittsburgh
National Human Genome Research Institute (NHGRI)
Related Conditions
- Mental Retardation1
- Hpe1
- Bronchopulmonary Dysplasia1
- Inguinal Hernia1
- Autism1